Lisa Pham
LightNews LightNews
banner
lisaphamwrites.bsky.social
Lisa Pham
@lisaphamwrites.bsky.social
1.2K followers 73 following 39 posts
Journalist and writer. Currently a reporter at Bloomberg News in London via Hong Kong, New York, Sydney. Previously freelanced for the International Herald Tribune and New York Times in Paris. Opinions are my own.
Posts Replies Media Videos
lisaphamwrites.bsky.social
Outside of journalism, I like to explore personal stories through creative writing. My memoir essay, “A refugee daughter’s pilgrimage,” is published in the latest issue of the Australian literary magazine Meanjin.
#memoir #lifewriting #refugees @meanjin.bsky.social
meanjin.com.au/memoir/a-ref...
A refugee daughter’s pilgrimage
I no longer flinch when someone asks if my family were boat people: it is a part of who I am. Their story is also my story.
meanjin.com.au
July 18, 2025 at 4:18 PM
lisaphamwrites.bsky.social
My colleagues and I wrote about how London’s bid to revive its shrinking stock market has faced a series of setbacks in recent weeks, with companies shifting listings and IPO plans from the market.
#markets #uk #stocks #stockmarket #stocklistings #ipos
www.bloomberg.com/news/article...
London Faces More Setbacks in a ‘Grueling Fight’ for Listings
London’s bid to revive its shrinking stock market has faced a series of setbacks in recent weeks, with companies shifting listings and IPO plans from the market.
www.bloomberg.com
June 6, 2025 at 9:36 AM
lisaphamwrites.bsky.social
I teamed up with a colleague to write about the divergence between two Swiss chocolate stocks amid soaring cocoa prices. Lindt shares are hovering near a record high, while Barry Callebaut fell to a 2011 low last month.
#markets #stocks #swiss #chocolate
www.bloomberg.com/news/article...
Swiss Chocolate Stocks Diverge as High Cocoa Prices Take Toll
Shares in two of Switzerland’s biggest chocolatiers are on markedly different courses this year as soaring cocoa prices prove a tougher obstacle for one than they do for the other.
www.bloomberg.com
June 6, 2025 at 9:30 AM
lisaphamwrites.bsky.social
ICYMI: I recently wrote about a clutch of volcanic islands in the Indian Ocean being the real-life battleground between a virus that could ignite a pandemic — chikungunya — and the first vaccine to address it.
#health #vaccines #chikungunya #prognosisnewsletter
www.bloomberg.com/news/newslet...
An Island Outbreak Becomes Testing Ground For New Vaccine Market
Hi, it’s Lisa in London, where I’m keeping an eye on the outbreak of a mosquito-borne disease in the Reunion Island, along with challenges facing the vaccine makers. But before we get to that...
www.bloomberg.com
June 6, 2025 at 9:24 AM
lisaphamwrites.bsky.social
ICYMI: I wrote about a blood test that could potentially speed up the time it takes for endometriosis to be diagnosed, for Bloomberg’s Prognosis newsletter last month.
#health #womenshealth #endometriosis #bloodtest #prognosisnewsletter
www.bloomberg.com/news/newslet...
Swapping a Scalpel for a Blood Test for Endometriosis Sufferers
Hi, it’s Lisa in London, where I’ve been learning about a blood test that could substantially speed up the time it takes for endometriosis to be diagnosed. But before we get to that...
www.bloomberg.com
June 6, 2025 at 9:18 AM
Reposted by Lisa Pham
nytimes.com
Breaking News: A baby with a rare disorder made medical history by receiving the first custom gene-editing treatment. The technique used has the potential to help people with thousands of other uncommon genetic diseases. nyti.ms/4j49xBy
A baby surrounded by medical devices is being held up by someone with gloved hands. A headline reads: "Baby Is Healed With World's First Personalized Gene-Editing Treatment." Photo courtesy of Children's Hospital of Pennsylvania.
May 15, 2025 at 5:09 PM
lisaphamwrites.bsky.social
My story published today looks at how hearing aids have been spared from US President Donald Trump’s trade war, with Europe’s dominance in this sector set to continue.
#hearingaids #tariffs #trump #europe #denmark #siliconvalleyofsound
www.bloomberg.com/news/article...
Trump’s Trade War Spares an Industry Europe Dominates: Hearing Aids
The roughly $12 billion global hearing aids sector is likely to continue to be led by Europe — especially Denmark — for some time to come.
www.bloomberg.com
May 15, 2025 at 7:55 PM
lisaphamwrites.bsky.social
ICYMI: I wrote about plant-based burgers for Bloomberg’s Prognosis newsletter last month.
#health #burgers #nutrition #plantbased #hrv #longcovid #prognosisnewsletter
www.bloomberg.com/news/newslet...
Why Some Plant-Based Burgers Are Healthier Than Others
Hi, it’s Lisa in London, where I’ve been wondering whether plant-based burgers can be considered healthy. But before we get to that...
www.bloomberg.com
May 15, 2025 at 7:46 PM
Reposted by Lisa Pham
propublica.org
New from @davidarmstrongx.bsky.social:

When I was diagnosed with cancer, I set out to understand why a single pill of Revlimid cost the same as a new iPhone. I’ve covered high drug prices as a reporter for years. What I discovered shocked even me.
The Price of Remission
When I was diagnosed with cancer, I set out to understand why a single pill of Revlimid cost the same as a new iPhone. I’ve covered high drug prices as a reporter for years. What I discovered shocked ...
www.propublica.org
May 8, 2025 at 11:30 AM
Reposted by Lisa Pham
nytimes.com
John Green has written a new, already best-selling nonfiction book on tuberculosis that asks a pointed question: Why does a fully curable disease still kill more than a million people a year? Read or listen to our conversation with the author. nyti.ms/4l6WykQ
March 27, 2025 at 11:12 PM
Reposted by Lisa Pham
nytimes.com
After the Trump administration abruptly cut $400 million in funding to Columbia University, dozens of medical and scientific studies are ending or at risk of ending, leaving researchers scrambling to find alternative funding.
Medical Research at Columbia Is Imperiled After Trump Terminates Funding
Dozens of medical and scientific studies are ending or at risk of ending, leaving researchers scrambling to find alternative funding.
www.nytimes.com
March 18, 2025 at 7:08 PM
Reposted by Lisa Pham
nytimes.com
Five years after the WHO declared the Covid-19 pandemic, scientists are getting a clearer picture of how the virus can lead to long-term, sometimes invisible changes.
Covid’s Long-Term Effects on the Lungs, Gut, Brain and More
Five years on, scientists are starting to understand how the virus can lead to long-term, sometimes invisible changes.
www.nytimes.com
March 10, 2025 at 6:35 PM
Reposted by Lisa Pham
propublica.org
NEW: Vaccines. Fluoride. Autism.

Communications involving these and 20 other “controversial, high profile, or sensitive” topics will get extra scrutiny under Health Secretary Robert F. Kennedy Jr.

By @anniewaldman.bsky.social and @lisalsong.bsky.social
National Cancer Institute Employees Can’t Publish Information on These Topics Without Special Approval
Vaccines. Fluoride. Autism. Communications involving these and 20 other “controversial, high profile, or sensitive” topics will get extra scrutiny under Health Secretary Robert F. Kennedy Jr.
propub.li
March 10, 2025 at 5:47 PM
lisaphamwrites.bsky.social
My latest piece for Bloomberg’s Prognosis newsletter is about a biotech company turning to llama antibodies in the search for new obesity drugs.
#health #biotech #obesitydrugs #llamas #prognosisnewsletter
www.bloomberg.com/news/newslet...
Llamas Are Now Being Used in Search for New Obesity Drugs
Hi, it’s Lisa in London, where I’ve been learning about llamas helping find potential obesity treatments for humans. But before we get to that...
www.bloomberg.com
March 7, 2025 at 1:10 PM
Reposted by Lisa Pham
kathryn42.bsky.social
Really proud of this piece. Grateful to Avalyn, Rowan and Sarah for sharing their stories. It's a national scandal that long Covid patients have been forgotten by the government, employers & society at large. The least we can do is keep talking about them

www.theguardian.com/society/2025...
‘We’re losing decades of our life to this illness’: long Covid patients on the fear of being forgotten
Five years on from March 2020, millions of people still face debilitating symptoms, with huge repercussions on public health and productivity. But politicians are starting to pretend the pandemic neve...
www.theguardian.com
March 2, 2025 at 8:26 AM
Reposted by Lisa Pham
jasongale.bsky.social
BREAKING: The Trump administration has canceled an upcoming meeting of the Food and Drug Administration’s vaccine advisory committee, a move that could complicate efforts to produce flu shots in time for the upcoming season. 1/2

www.bloomberg.com/news/article...
Trump Administration Cancels Meeting of FDA Vaccine Advisers, Risking Flu-Shot Delay
The Trump administration has canceled an upcoming meeting of the Food and Drug Administration’s vaccine advisory committee, a move that could complicate efforts to produce flu shots in time for the up...
www.bloomberg.com
February 27, 2025 at 5:45 AM
Reposted by Lisa Pham
annecronin.bsky.social
SCOOP > The Trump administration is weighing pulling Moderna's contract to create bird flu shots, part of a bigger effort to question spending on messenger RNA-based vaccines

Madison Muller, @rileyraygriffin.bsky.social and @ikeswetlitz.bsky.social

www.bloomberg.com/news/article...
Trump Team Weighs Pulling Funding for Moderna Bird Flu Vaccine
US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to Moderna Inc., people familiar with the matter said.
www.bloomberg.com
February 26, 2025 at 10:46 PM
lisaphamwrites.bsky.social
Asparagus tart with Gruyère cheese. #homecooking #sundaylunch
February 23, 2025 at 10:47 PM
lisaphamwrites.bsky.social
Novo Nordisk shares had their worst week this year, after a Super Bowl advertisement touting copycat products underscored the challenge to its weight-loss blockbuster drug. Here’s my story with Naomi Kresge via @bloomberg.com
#markets #shares #weightlossdrugs
www.bloomberg.com/news/article...
Novo Shares Hit as Super Bowl Weight-Loss Ad Shows Copycat Risk
Novo Nordisk A/S shares are on track for their worst week this year, after a Super Bowl advertisement touting copycat products underscored the challenge to its weight-loss blockbuster drug.
www.bloomberg.com
February 14, 2025 at 4:32 PM
lisaphamwrites.bsky.social
Why a food dye that’s getting banned in the US is staying in cocktail cherries in the UK — here’s my latest piece for Bloomberg’s Prognosis newsletter.
#health #food #artificialfooddyes #cocktailcherries #prognosisnewsletter
www.bloomberg.com/news/newslet...
Why a Food Dye Banned in the US Will Stay in UK Cocktail Cherries
Hi, it’s Lisa in London, where I’ve been pondering the health risks associated with artificial dyes that can be found in cake ingredients, cocktail cherries and more. But before we get to that...
www.bloomberg.com
February 11, 2025 at 2:11 PM
Reposted by Lisa Pham
stephanienolen.bsky.social
The Trump administration's stop-work order on USAID left thousands of volunteers around the world w/ experimental drugs + medical devices in their bodies – cut off from care by researchers running clinical trials, in violation of the fundamental principles of research www.nytimes.com/2025/02/06/h...
Dozens of Clinical Trials Have Been Frozen in Response to Trump’s USAID Order
The stop-work order on U.S.A.I.D.-funded research has left thousands of people with experimental drugs and devices in their bodies, with no access to monitoring or care.
www.nytimes.com
February 7, 2025 at 1:48 AM
lisaphamwrites.bsky.social
Drugmaker Novo Nordisk will report earnings next week, but there’s still a long way to go to claw back the stock declines of the past six months. Here’s my story published today via @bloomberg.com
#markets #shares #pharma
www.bloomberg.com/news/article...
Novo Nordisk Shares Still Have a Long Road Back from 40% Slump
Novo Nordisk A/S investors got a much-needed boost from last week’s trial results for an experimental weight-loss shot. But there’s still a long way to go to claw back the declines of the past six mon...
www.bloomberg.com
January 31, 2025 at 2:21 PM
lisaphamwrites.bsky.social
My story published today looks at how hearing-aid makers have become one of the stock market’s less likely artificial intelligence plays. Via @bloomberg.com
#markets #stocks #hearingaids #ai
www.bloomberg.com/news/article...
Swiss Hearing-Aid Maker Transforms Into Unlikely AI Stock Winner
Hearing-aid makers have become one of the stock market’s less likely artificial intelligence plays.
www.bloomberg.com
January 30, 2025 at 1:09 PM
lisaphamwrites.bsky.social
Danish drugmaker Novo Nordisk lost its crown as Europe’s most valuable listed company on Friday, after its market capitalisation fell below that of French luxury-goods maker LVMH. Here’s my story with Kit Rees via @bloomberg.com
#markets #stocks
www.bloomberg.com/news/article...
LVMH Reclaims Title of Europe’s Most Valuable Stock From Novo
It’s taken LVMH nearly a year-and-a-half to regain its spot as Europe’s biggest stock from Novo Nordisk A/S.
www.bloomberg.com
January 17, 2025 at 4:47 PM
lisaphamwrites.bsky.social
My latest article published today is about Alzheimer’s drugs and the developments to watch this year, as investors eye the next obesity-like market opportunity. Via @bloomberg.com
#markets #stocks #alzheimersdrugs
www.bloomberg.com/news/article...
Alzheimer’s Drugs Eyed by Investors Seeking Obesity-Like Gains
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for Alzheimer’s disease in 2025.
www.bloomberg.com
January 10, 2025 at 12:01 PM